Que Veut Dire FOR GUIDANCE ON en Français - Traduction En Français

• for guidance on

Exemples d'utilisation de For guidance on en Espagnol et leurs traductions en Français

Note for Guidance on Repeated dose toxicity Adoptada en julio de 2000.
Note for Guidance on Repeated dose toxicity Adoptée en juillet 2000.

Título del documento Revision of Note for guidance on carcinogenic potential 3BS7a, Volume 3B, 1998, p.
Titre du document Revision of Note for guidance on carcinogenic potential 3BS7a, Volume 3B, 1998, p.

Note for Guidance on Parametric Release Publicada para consulta en marzo de 2000.
Note for Guidance on Parametric Release Transmise pour consultation en mars 2000.

Concept Paper on the Development of a CPMP/CVMP Note for Guidance on Quality of Water for Pharmaceutical Use Adoptada en julio de 2000.
Concept Paper on the Development of a CPMP/CVMP Note for Guidance on Quality of Water for Pharmaceutical Use Adoptée en juillet 2000.

Note for guidance on quality of modified release Adoptada en julio de 1999 products.
Note for guidance on quality of modified release Adopté en juillet 1999 products.

Core SPC for Human albumin Publicada para consulta en junio de 2000 Note for Guidance on the Clinical investigation of plasma derived antithrombin products Publicada para consulta en diciembre de 2000.
Core SPC for Human albumin Transmise pour consultation en juin 2000 Note for Guidance on the Clinical investigation of plasma derived antithrombin products Transmise pour consultation en décembre 2000.

Note for guidance on quality of herbal medicinal products Publicada para consulta en noviembre de 2000.
Note for guidance on quality of herbal medicinal products Transmise pour consultation en novembre 2000.

Por otra parte, la Directriz más reciente de la UE se estableció en 1994 Note for Guidance on the evaluation on the pharmacokinetics of medicinal products in patients with imparied renal function, CHMP/ EWP/ 225/ 02.
De plus, la ligne directrice de l'UE la plus récente n'a été définie qu'en 1994 Note for Guidance on the evaluation on the pharmacokinetics of medicinal products in patients with impaired renal function[Note d'orientation sur l'évaluation de la pharmacocinétique des médicaments chez les patients dont la fonction hépatique est altérée], CHMP/ EWP/ 225/ 02.

Note for Guidance on clinical investigation of steroid contraceptives in woman Adoptada en febrero de 2000.
Note for Guidance on clinical investigation of steroid contraceptives in woman Adoptée en février 2000.

Título del documento Points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with ST segment elevation acute myocardial infarction(STEMI) Note for Guidance on the clinical development of medicinal products for the treatment of HIV infection.
Titre du document Points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with ST segment elevation acute myocardial infarction(STEMI) Note for Guidance on the clinical development of medicinal products for the treatment of HIV infection.

Título del documento Note for guidance on postmenopausal osteoporosis in women.
Titre du document Note for guidance on postmenopausal osteoporosis in women.

Note for Guidance on the Clinical investigation of recombinant factor VIII and IX products Adoptada en octubre de 2000.
Note for Guidance on the Clinical investigation of recombinant factor VIII and IX products Adoptée en octobre 2000.

Título del documento Position Paper on the Non-clinical safety studies to support clinical trials with a single low dose of a compound Note for Guidance on specification limits for residues of metal catalysts Note for Guidance on Comparability of Medicinal Products Containing Biotechnology-derived Proteins as Drug Substance.
Titre du document Position Paper on the Non-clinical safety studies to support clinical trials with a single low dose of a compound Note for Guidance on specification limits for residues of metal catalysts Note for Guidance on Comparability of Medicinal Products Containing Biotechnology-derived Proteins as Drug Substance.

Note for Guidance on Medicinal Gases- Pharmaceutical Information Publicada para consulta en julio de 2000.
Note for Guidance on Medicinal Gases- Pharmaceutical Information Transmise pour consultation en juillet 2000.

Título del documento Note for Guidance on the Clinical Investigation of Plasma derived Antithrombin Products.
Titre du document Note for Guidance on the Clinical Investigation of Plasma derived Antithrombin Products.

Note for Guidance on the Clinical investigation of human plasma derived factor VIII and IX products Adoptada en octubre de 2000.
Note for Guidance on the Clinical investigation of human plasma derived factor VIII and IX products Adoptée en octobre 2000.

Concept paper on the Development of a CPMP Note for Guidance on the Clinical investigation of medicinal products in pain management Adoptada en junio de 2000.
Concept paper on the Development of a CPMP Note for Guidance on the Clinical investigation of medicinal products in pain management Adoptée en juin 2000.

Note for guidance on the Clinical investigation of human anti-D immunoglobulin for intravenous and/or intramuscular use Adoptada en junio de 2000.
Note for guidance on the Clinical investigation of human anti-D immunoglobulin for intravenous and/or intramuscular use Adoptée en juin 2000.

Concept paper on the development of a CPMP Note for Guidance on the clinical investigation of medicinal products in the treatment of asthma Adoptada en febrero de 2000.
Concept paper on the development of a CPMP Note for Guidance on the clinical investigation of medicinal products in the treatment of asthma Adoptée en février 2000.

Note for Guidance on Evaluation of anticancer medicinal products in man Publicada para consulta en julio de 2000 y ampliado el plazo dos meses más en septiembre de 2000.
Note for Guidance on Evaluation of anticancer medicinal products in man Transmise pour consultation en juillet 2000 avec extension en septembre 2000 de deux mois supplémentaires.

Concept paper on the Development of a CPMP Note for Guidance on Clini- cal investigation of medicinal products in the treatment of diabetes mellitus Adoptada en julio de 2000.
Concept paper on the Development of a CPMP Note for Guidance on Clini- cal investigation of medicinal products in the treatment of diabetes mellitus Adoptée en juillet 2000.

Note for guidance on specifications- Test Adoptada en noviembre de 1999 procedures and acceptance criteria for new drug substances and new drug products- chemical substances.
Note for guidance on specifications- Test Adopté en novembre 1999 procedures and acceptance criteria for new drug substances and new drug products- chemical substances.

Core SPC for Human albumin Adoptada en octubre de 2000 Note for guidance on the Clinical investigation of human plasma derived factor VIII and IX products Publicada para consulta en junio de 2000.
Core SPC for Human albumin Adoptée en octobre 2000 Note for guidance on the Clinical investigation of human plasma derived factor VIII and IX products Transmise pour consultation en juin 2000.

Note for guidance on specifications: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products Publicada para consulta en noviembre de 2000.
Note for guidance on specifications: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products Transmise pour consultation en novembre 2000.

Número de referencia Título del documento CPMP/ BWP/ 2490/ 00 Note for guidance on Cell Culture Inactivated Influenza Vaccines Annex to NfG on Harmonisation of requirements for Influenza Vaccines CPMP/ BWP/ 214/ 96.
Numéro de référence Titre du document CPMP/ BWP/ 2490/ 00 Note for guidance on Cell Culture Inactivated Influenza Vaccines Annex to NfG on Harmonisation of requirements for Influenza Vaccines CPMP/ BWP/ 214/ 96.

Título del documento Note for Guidance on the Clinical investigation of plasma derived fibrin sealants Note for guidance on the Clinical investigation of von Willebrand factor Warning on transmissible agents for patient leaflets and SPCs Core SPC for Plasma derived fibrin sealants.
Titre du document Note for Guidance on the Clinical investigation of plasma derived fibrin sealants Note for guidance on the Clinical investigation of von Willebrand factor Warning on transmissible agents for patient leaflets and SPCs Core SPC for Plasma derived fibrin sealants.

Título del documento Concept paper for the development of the revision of the CPMP Note for Guidance on evaluation of new anti- bacterial medicinal products(CPMP/ EWP/ 558/ 95) and the CPMP Note for Guidance on the pharmacodynamic section of the SPC for anti-bacterial medicinal products CPMP/ EWP/ 520/ 96.
Titre du document Concept paper for the development of the revision of the CPMP Note for Guidance on evaluation of new anti- bacterial medicinal products(CPMP/ EWP/ 558/ 95) and the CPMP Note for Guidance on the pharmacodynamic section of the SPC for anti-bacterial medicinal products CPMP/ EWP/ 520/ 96.

Título del documento Note for Guidance on the Use of Bovine Serum in the manufacture of Human Biological Medicinal Products Points to Consider on Quality Aspects of Medicinal Products containing Active Substances Produced by Stable Transgene Expression in Higher Plants Revision of Note for guidance on minimising the risks of TSE transmission via medicinal products Points to Consider on the Development of Live Attenuated Influenza Vaccines.
Titre du document Note for Guidance on the Use of Bovine Serum in the manufacture of Human Biological Medicinal Products Points to Consider on Quality Aspects of Medicinal Products containing Active Substances Produced by Stable Transgene Expression in Higher Plants Revision of Note for guidance on minimising the risks of TSE transmission via medicinal products Points to Consider on the Development of Live Attenuated Influenza Vaccines.

Título del documento Note for Guidance on Criteria for Recall and Repackaging Following Urgent Safety Restriction and Variation Procedures CPMP Points-to-Consider Document on Xenogeneic Cell Therapy(CPMP/ 1199/ 02) ICH-V1.
Titre du document Note for Guidance on Criteria for Recall and Repackaging Following Urgent Safety Restriction and Variation Procedures CPMP Points-to-Consider Document on Xenogeneic Cell Therapy(CPMP/ 1199/ 02) ICH-V1.

Título del documento Revision of Note for guidance on the conduct of pharmacovigilance for centrally authorised products Revision of crisis management plan regarding centrally authorised products for human use Guidance document for the implementation of the position paper on compliance with pharmacovigilance regulatory obligations Contribution to Note for guidance on the use of medicinal products during pregnancy.
Titre du document Revision of Note for guidance on the conduct of pharmacovigilance for centrally authorised products Revision of crisis management plan regarding centrally authorised products for human use Guidance document for the implementation of the position paper on compliance with pharmacovigilance regulatory obligations Contribution to Note for guidance on the use of medicinal products during pregnancy.

Comment utiliser "for guidance on" dans une phrase en Espagnol

Note for guidance on repeated dose toxicity.

Looking for guidance on financing your home?

Organizing seminars for guidance on UPSC Examinations.

Click here for guidance on enabling cookies.

Use ANSI Z358.1-1998 for guidance on compliance.

For guidance on occasional badges, click here.

Looking for guidance on rewriting meta descriptions?

See moodledocs for guidance on Marking Guide.

See Radioactive Shrapnel for guidance on management.

See here for guidance on dyeing wool.

Comment utiliser "for guidance on" dans une phrase en Français

Contact us for information about how to include playa restoration as part of a municipal water plan or for guidance on how to restore playas.

Et l’une des principales recommandations est la Note for guidance on the clinical evaluation of vaccine.

Click here to read our full cookie policy and for guidance on changing your cookie settings.

Be sure to check your Union Contract or Shop Steward for guidance on posting in your workplace.

For guidance on Need-to-Know refer to the DoD Manual 5200.02 effective April 3, 2017.

Many stakeholders, including investors, have asked for guidance on how companies should report on how they are implementing the UN Guiding Principles.